Demeckova, V.; Mudronova, D.; Gancarcikova, S.; Kubatka, P.; Kajo, K.; Kassayova, M.; Bojkova, B.; Adamkov, M.; Solár, P.
5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN. Int. J. Mol. Sci. 2022, 23, 6374.
https://doi.org/10.3390/ijms23126374
AMA Style
Demeckova V, Mudronova D, Gancarcikova S, Kubatka P, Kajo K, Kassayova M, Bojkova B, Adamkov M, Solár P.
5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN. International Journal of Molecular Sciences. 2022; 23(12):6374.
https://doi.org/10.3390/ijms23126374
Chicago/Turabian Style
Demeckova, Vlasta, Dagmar Mudronova, Sona Gancarcikova, Peter Kubatka, Karol Kajo, Monika Kassayova, Bianka Bojkova, Marian Adamkov, and Peter Solár.
2022. "5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN" International Journal of Molecular Sciences 23, no. 12: 6374.
https://doi.org/10.3390/ijms23126374
APA Style
Demeckova, V., Mudronova, D., Gancarcikova, S., Kubatka, P., Kajo, K., Kassayova, M., Bojkova, B., Adamkov, M., & Solár, P.
(2022). 5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN. International Journal of Molecular Sciences, 23(12), 6374.
https://doi.org/10.3390/ijms23126374
